John W. Clader
60Patents
18h-index
97Co-inventors
87Inventor score
Filing activity: Jul 10, 1987 → Oct 2, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5767115A | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents | Emerging Cross-Sectional Technologies | 118 | Expired |
| US5238950A | Inhibitors of platelet-derived growth factor | Chemistry; Metallurgy | 89 | Expired |
| US5883096A | Muscarinic antagonists | Chemistry; Metallurgy | 74 | Expired |
| US5846966A | Combinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase Inhibitors | Emerging Cross-Sectional Technologies | 58 | Expired |
| US5889006A | Muscarinic antagonists | Chemistry; Metallurgy | 58 | Expired |
| US4916145A | Substituted n-[(pyridyl)alkyl]aryl-carboxamide | Chemistry; Metallurgy | 56 | Expired |
| US6689765B2 | Piperazine derivatives useful as CCR5 antagonists | Chemistry; Metallurgy | 49 | Expired |
| US5656624A | 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents | Chemistry; Metallurgy | 48 | Expired |
| US5631365A | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents | Emerging Cross-Sectional Technologies | 47 | Expired |
| US6969719B2 | Polycyclic guanine phosphodiesterase V inhibitors | Human Necessities | 44 | Expired |
| US5688787A | Substituted .beta.-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof | Chemistry; Metallurgy | 44 | Expired |
| US6037352A | Muscarinic antagonists | Chemistry; Metallurgy | 44 | Expired |
| US6391865B1 | Piperazine derivatives useful as CCR5 antagonists | Chemistry; Metallurgy | 43 | Expired |
| USRE37721E1 | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents | General | 43 | Expired |
| US5698548A | Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents | Chemistry; Metallurgy | 38 | Expired |
| US6387930B1 | Piperidine derivatives useful as CCR5 antagonists | Chemistry; Metallurgy | 34 | Expired |
| US6294554A | Muscarinic antagonists | Chemistry; Metallurgy | 29 | Expired |
| US6043255A | Muscarinic antagonists | Chemistry; Metallurgy | 23 | Expired |
| US4973586A | Fused benzazepines, compositions of, and medical use thereof | Chemistry; Metallurgy | 12 | Expired |
| US6288068A | Muscarinic antagonists | Chemistry; Metallurgy | 11 | Expired |
| US6472394B1 | MCH antagonists and their use in the treatment of obesity | Chemistry; Metallurgy | 11 | Expired |
| US7208486B2 | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6900329B2 | MCH antagonists and their use in the treatment of obesity | Chemistry; Metallurgy | 7 | Expired |
| US6602885B2 | Piperidine derivatives useful as CCR5 antagonists | Chemistry; Metallurgy | 7 | Expired |
| US8450343B2 | Gamma secretase modulators | Chemistry; Metallurgy | 7 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.